Balto Pharmaceuticals provides research and development of drugs for cancer diseases.
Balto Pharmaceuticals has raised $2.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2023.
Balto Pharmaceuticals is headquartered in South Pasadena, United States.
Balto Pharmaceuticals provides research and development of drugs for cancer diseases.
Balto Pharmaceuticals is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Balto Pharmaceuticals — Funding & Investors." VCBacked, September 13, 2023, https://www.vcbacked.co/company/balto-pharmaceuticals. Accessed September 30, 2026.
VCBacked. (2023). Balto Pharmaceuticals — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/balto-pharmaceuticals
{{cite web |title=Balto Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/balto-pharmaceuticals |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated